Dr. Daniel Aaron Rontal, MD

Dr. Rontal practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health.

Dr. Rontal's NPI, 1831152610, was assigned on April 11, 2006. Dr. Rontal graduated from Perelman School of Med at the University of Pennsylvania in 2000. Dr. Rontal holds Michigan license 4301076001.

Dr. Rontal's primary practice is Corewell Health William Beaumont University Hospital, at 3601 W Thirteen Mile Rd, Royal Oak, MI 48073 in Oakland County. The practice phone is (248) 898-5400.

Dr. Rontal's primary practice is Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health. Dr. Rontal is also affiliated with Corewell Health Beaumont Troy Hospital. The medical group on file is The Rontal Clinic. Dmand AI also links Dr. Rontal to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rontal practices, 7 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Rontal's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Rontal is licensed in Michigan.

CMS data shows 2,420 Medicare services from Dr. Rontal across 13 procedure codes in 2024, for 874 Medicare patients. Medicare paid $154,308 for them. Every service was in an office.

CMS counts 874 Medicare patients who saw Dr. Rontal in 2024. The largest group is 65 to 74, with 355 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rontal's median patient age at 66, with 55% women.

In 2024, Dr. Rontal wrote 1,295 Medicare Part D claims for 532 patients. 97% of them were for generic drugs. CMS names the drug for 1,164 of them, across 23 drugs with 11 or more claims each, at $43,258 in total drug cost. In 2023, CMS named 1,155 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Rontal for performance year 2024, reported individually. Dr. Rontal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Rontal to 1 clinical trial. Open Payments lists research payments to Dr. Rontal that name 1 trial.

CMS Open Payments shows 120 general payments to Dr. Rontal from 31 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 37% of the total. Intersect ENT, Inc. paid the most, $23,045. It also lists 13 research payments totaling $52,166 from 2016 to 2025, naming 1 clinical trial.

Dr. Rontal graduated from Perelman School of Med at the University of Pennsylvania in 2000.